Search research articles
Contact Us
Filters
Showing results (101-110 of 129) with videos related to
Page
of 13
Sort By:
Journal of Affective Disorders
|
December 21, 2000
Maintenance therapies for classic and other forms of bipolar disorder
C L Bowden, Y Lecrubier, M Bauer, et al.
L'Encephale
|
November 1, 1989
[Clonidine versus a placebo trial in manic disorder]
M C Hardy-Bayle, Y Lecrubier, S Lancrenon, et al.
The Journal of Clinical Psychiatry
|
July 11, 2002
Consensus statement on depression, anxiety, and cardiovascular disease
J C Ballenger, J R Davidson, Y Lecrubier, et al.
Revue D'Epidemiologie Et De Sante Publique
|
December 10, 1999
[Use of a structured diagnostic interview to identify depressive episodes in an epidemiologic study: a posteriori internal validation]
A Duburcq, P Blin, Y Charpak, et al.
The Journal of Clinical Psychiatry
|
July 11, 2002
Consensus statement on depression, anxiety, and functional gastrointestinal disorders
J C Ballenger, J R Davidson, Y Lecrubier, et al.
The Journal of Clinical Psychiatry
|
July 11, 2002
Consensus statement on depression, anxiety, and oncology
J C Ballenger, J R Davidson, Y Lecrubier, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 19, 1999
Treatment resistant depression: methodological overview and operational criteria
D Souery, J Amsterdam, C de Montigny, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1995
A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers
I Berlin, S Saïd, O Spreux-Varoquaux, et al.
Neuropsychobiology
|
June 16, 2001
Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia
Y Lecrubier, M Azorin, T Bottai, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 1, 2004
ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder
S A Montgomery, Y Lecrubier, D S Baldwin, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 129) with videos related to
Sort By:
Page
of 13
Journal of Affective Disorders
|
December 21, 2000
Maintenance therapies for classic and other forms of bipolar disorder
C L Bowden, Y Lecrubier, M Bauer, et al.
L'Encephale
|
November 1, 1989
[Clonidine versus a placebo trial in manic disorder]
M C Hardy-Bayle, Y Lecrubier, S Lancrenon, et al.
The Journal of Clinical Psychiatry
|
July 11, 2002
Consensus statement on depression, anxiety, and cardiovascular disease
J C Ballenger, J R Davidson, Y Lecrubier, et al.
Revue D'Epidemiologie Et De Sante Publique
|
December 10, 1999
[Use of a structured diagnostic interview to identify depressive episodes in an epidemiologic study: a posteriori internal validation]
A Duburcq, P Blin, Y Charpak, et al.
The Journal of Clinical Psychiatry
|
July 11, 2002
Consensus statement on depression, anxiety, and functional gastrointestinal disorders
J C Ballenger, J R Davidson, Y Lecrubier, et al.
The Journal of Clinical Psychiatry
|
July 11, 2002
Consensus statement on depression, anxiety, and oncology
J C Ballenger, J R Davidson, Y Lecrubier, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 19, 1999
Treatment resistant depression: methodological overview and operational criteria
D Souery, J Amsterdam, C de Montigny, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1995
A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers
I Berlin, S Saïd, O Spreux-Varoquaux, et al.
Neuropsychobiology
|
June 16, 2001
Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia
Y Lecrubier, M Azorin, T Bottai, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 1, 2004
ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder
S A Montgomery, Y Lecrubier, D S Baldwin, et al.
Page
of 13